Genetic Technologies
GENE
$2.28
Share price
0.88%
Change (1 day)
132.65%
Change (1 year)
Categories
Genetic Technologies (GENE) - Total assets
Total assets on the balance sheet as of December 2023 : $5.77 M
According to Genetic Technologies's latest financial reports the company's total assets are $5.77 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Genetic Technologies - Total assets on balance sheet (from 2004 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | $9.83 M | -31.29% |
| 2022-06-30 | $14.31 M | -17.08% |
| 2021-06-30 | $17.26 M | 60.67% |
| 2020-06-30 | $10.74 M | 368.48% |
| 2019-06-30 | $2.29 M | -49.73% |
| 2018-06-30 | $4.56 M | -50.98% |
| 2017-06-30 | $9.3 M | -6.26% |
| 2016-06-30 | $9.92 M | -37.56% |
| 2015-06-30 | $15.89 M | 150.88% |
| 2014-06-30 | $6.33 M | -16.56% |
| 2013-06-30 | $7.59 M | -54.89% |
| 2012-06-30 | $16.83 M | 76.46% |
| 2011-06-30 | $9.54 M | 36.96% |
| 2010-06-30 | $6.96 M | -51.94% |
| 2009-06-30 | $14.49 M | -37.21% |
| 2008-06-30 | $23.08 M | -8.78% |
| 2007-06-30 | $25.3 M | 51.81% |
| 2006-06-30 | $16.66 M | -13.86% |
| 2005-06-30 | $19.35 M | 30.71% |
| 2004-06-30 | $14.8 M | 148.03% |
| 2003-06-30 | $5.96 M | -3.96% |
| 2002-06-30 | $6.21 M | -27.23% |
| 2001-06-30 | $8.54 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $98.72 B | 1,709,494.41% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $13.95 B | 241,535.24% | 🇺🇸 USA |
 Danaher DHR | $83.40 B | 1,444,135.49% | 🇺🇸 USA |
 LabCorp LH | $16.53 B | 286,160.00% | 🇺🇸 USA |
 Compugen CGEN | $0.12 B | 2,001.09% | 🇮🇱 Israel |
 Neogen NEOG | $4.58 B | 79,252.95% | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.14 B | 19,753.43% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $49.13 M | 750.80% | 🇺🇸 USA |